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Introduction {#sec1}
============

In vivo cell function depends on dynamic cues provided by a 3D microenvironment that includes soluble and sequestered biomolecules, an extracellular matrix (ECM), and other cell types ([@bib41]). Thus, while most in vitro studies in cell biology use planar substrates such as tissue-culture polystyrene (TCP) plates, cellular models have increasingly relied on culture platforms such as reconstituted ECM gels to recapitulate features of native tissues ([@bib55]). In vitro vascular network formation was first reported for endothelial cells more than three decades ago ([@bib16]), and early studies demonstrated the importance of the ECM for guiding capillary network formation ([@bib34], [@bib35]). Thus, vascular biologists were among the first to widely adopt naturally derived ECM materials such as collagen ([@bib10], [@bib11], [@bib37]), fibrin ([@bib38], [@bib44]), and Matrigel ([@bib2], [@bib26]) for investigating blood vessel formation.

Gels formed from reconstituted ECM proteins retain complex features of native tissue, such as fibrillar structure and cellular adhesion sites, but also introduce experimental uncertainties due to batch-to-batch variability and poorly defined compositions ([@bib22], [@bib69]). Limitations inherent to reconstituted protein gels have motivated efforts to design synthetic polyethylene glycol (PEG) hydrogels and other engineered materials that use modular chemistries to provide spatial and temporal control over the presentation of bioactive molecules (e.g., peptides) ([@bib14], [@bib25], [@bib33], [@bib49], [@bib67]); such materials have been used to investigate biochemical and mechanical factors that promote in vitro and in vivo vascularization ([@bib6], [@bib8], [@bib27], [@bib39], [@bib42], [@bib47], [@bib63], [@bib72]). However, while engineered culture platforms have gained acceptance within the biomedical engineering community, reconstituted ECM gels are still viewed as the "gold standard" for modeling tissue assembly in vitro.

The goal of this study was to understand how synthetic hydrogels influence global biological function compared with standard 2D or 3D cell-culture formats. Vascular morphogenesis was chosen as a model biological system, and a bioinformatics approach was employed to provide genome-wide analysis for H1 embryonic stem cell (ESC)-derived endothelial cells (H1-ECs), primary human pericytes, and human umbilical vein endothelial cells (HUVECs) in 2D or 3D culture. Human pluripotent stem cells provide a scalable endothelial cell source for vascular modeling ([@bib5], [@bib24], [@bib32], [@bib43], [@bib46], [@bib50], [@bib66]), and H1-ECs were derived in the present study with \>90% efficiency without a sorting step by optimizing a previous protocol ([@bib53]). PEG hydrogels formed via thiolene photopolymerization ([@bib14]) were chosen as a synthetic scaffold based on previous studies, which demonstrated that the only bioactive components necessary to promote vascular network formation by primary ([@bib42]) and induced pluripotent stem cell (iPSC)-derived ([@bib72]) endothelial cells are matrix metalloproteinase (MMP)-degradable peptide crosslinks ([@bib40]) and pendant CRGDS cell adhesion peptide ([@bib48]). RNA sequencing (RNA-seq) was used to generate global gene expression profiles ([Table S1](#mmc2){ref-type="supplementary-material"}) for endothelial cells or pericytes in 2D or 3D culture, and differentially expressed genes were evaluated for functional characteristics using The DAVID Bioinformatics Database Functional Annotation Tool (v6.7) ([@bib3], [@bib12], [@bib21]). Our combined results provide valuable insight into roles for cellular and extracellular context when modeling cellular self-organization in vitro.

Results {#sec2}
=======

A Fully Defined, High-Efficiency Protocol for Generating Endothelial Cells from Human Pluripotent Stem Cells {#sec2.1}
------------------------------------------------------------------------------------------------------------

The defined protocol chosen for the present study was previously used to derive endothelial cells from H1-ESCs, which successfully vascularized model neural tissues in vitro ([@bib53]). Here, we extended our previous work by deriving endothelial cells from both human ESCs ([@bib61]) and iPSCs ([@bib60], [@bib70]) to demonstrate the robustness of the protocol and by thoroughly characterizing the endothelial phenotype of H1-ECs. The 5-day protocol proceeds through a mesoderm intermediate step ([@bib71]) and uses defined components that include recombinant vitronectin-coated plates and modified E8 media formulations ([Figure 1](#fig1){ref-type="fig"}A) ([@bib7]). H1 ESCs generated 74% ± 2% endothelial cells after 5 days of differentiation and purity was increased to 90% ± 1% with an additional passage (day 7, [Figure 1](#fig1){ref-type="fig"}B). Modification of the protocol to include CHIR 99021 (a Wnt agonist) in the mesoderm differentiation medium increased purity to 85% ± 3% and 96% ± 3% for H1-ECs at day 5 and day 7, respectively ([Figure S1](#mmc1){ref-type="supplementary-material"}). The modified protocol also yielded 59%--95% endothelial cells from five additional human PSC lines ([Figure S1](#mmc1){ref-type="supplementary-material"}), and further passage of the DF19-11 (the lowest yield) and PBMC-3-1 (the highest yield) iPSC-derived endothelial cells increased purity to 71% and 99%, respectively.

H1-ECs were characterized by upregulated vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) and downregulated NANOG and OCT4 by fluorescence-activated cell sorting (FACS) analysis ([Figure 1](#fig1){ref-type="fig"}C), and reduced expression of H1 ESC enriched genes by RNA-seq ([Figure 1](#fig1){ref-type="fig"}D; "H1-EC1," E8BA protocol, −CHIR; "H1-EC2," E8BAC protocol, +CHIR). H1-ECs also took up low-density lipoprotein (LDL) ([Figure 1](#fig1){ref-type="fig"}E) and formed capillary networks in Matrigel in vitro ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}) and in vivo ([Figure 1](#fig1){ref-type="fig"}G). Spearman\'s rank correlation analysis demonstrated that H1-EC gene expression was more closely correlated with primary HUVECs than H1 ESCs or pericytes ([Figure S2](#mmc1){ref-type="supplementary-material"}). Finally, differential gene expression analysis via the R package EBSeq (false discovery rate \[FDR\] ≤0.005) ([@bib29]) demonstrated that genes upregulated for H1-ECs and HUVECs over control H1 ESCs were associated with gene ontology (GO) ([@bib3], [@bib12], [@bib21]) categories relevant to endothelial phenotypes ([Figure 1](#fig1){ref-type="fig"}H and [Table S2](#mmc3){ref-type="supplementary-material"}). These results demonstrate that the defined protocol efficiently produced endothelial cells with characteristic gene expression profiles, protein expression, and functional properties.

H1-ECs and Pericytes Cocultured in PEG Hydrogels or Matrigel Were Characterized by Similar Gene Expression Profiles {#sec2.2}
-------------------------------------------------------------------------------------------------------------------

Cocultured H1-ECs and pericytes (H1-EC-PC) formed interconnected vascular networks and activated similar patterns of expressed genes in PEG hydrogels with 35%--60% crosslinking density ([Figures 2](#fig2){ref-type="fig"}A--2C and [S3](#mmc1){ref-type="supplementary-material"}) or in Matrigel ([Figure 2](#fig2){ref-type="fig"}D). H1-EC-PC cocultures were characterized by Spearman\'s coefficients (ρ) of ≥0.98 for all comparisons between PEG hydrogels and Matrigel on the same day ([Figure S2](#mmc1){ref-type="supplementary-material"}), demonstrating that global gene expression profiles were similar for matrices with widely varying properties. EBSeq analysis ([@bib29]) demonstrated that the total number of differentially expressed genes was higher for H1-EC-PC cocultures when comparing PEG hydrogels and Matrigel (on the same day) than for comparisons between PEG hydrogels with different crosslinking densities ([Table S3](#mmc4){ref-type="supplementary-material"}), but that ≥85% of the differentially expressed genes for H1-EC-PCs in Matrigel relative to H1 ESCs were also identified in PEG hydrogels on each day ([Table S3](#mmc4){ref-type="supplementary-material"}, "DE Lists"). Genes upregulated by H1-EC-PC cocultures over H1 ESCs in both materials were similarly enriched within the GO category vasculature development (GO:0001944) and others relevant to vascular network formation ([Figure 2](#fig2){ref-type="fig"}E and [Table S3](#mmc4){ref-type="supplementary-material"}, "GO Terms"). These upregulated genes included basement membrane (e.g., *COL4A1*, *COL4A2*, *LAMA4*, *LAMB1*, *LAMB3*) and other ECM components (e.g., *COL1A1*, *COL1A2*, *COL3A1*, *FN1*, *CSPG4*, *HSPG2*), adhesion and cell-cell junction molecules (e.g., *ITGA1*, *ITGA2*, *ITGB3*, *CLDN5*, *CDH5*), and regulators of proteolysis (e.g., *MMP1*, *MMP14*, *TIMP1*, *TIMP3*), Notch signaling (e.g., *DLL4*, *NOTCH4*, *GJA4*), and lumen formation (e.g., *RASIP1*, *CD99*) ([@bib18]) ([Table S3](#mmc4){ref-type="supplementary-material"}). Similarities between H1-EC-PC cocultures in PEG hydrogels and Matrigel were also evident based on heatmaps for normalized expression of genes associated with vasculature development ([Figure 3](#fig3){ref-type="fig"}), ECM components, and cell adhesion ([Table S3](#mmc4){ref-type="supplementary-material"}, "Heatmaps"). Genes upregulated by monocultured endothelial cells in PEG hydrogels or Matrigel over H1 ESCs were also similarly enriched within GO categories relevant to vascular function ([Table S2](#mmc3){ref-type="supplementary-material"}, "GO Summary"). Thus, similar global gene expression patterns are activated for 3D vascular models that use PEG hydrogels or Matrigel.

Differential Gene Expression Provides Insight into Distinct Roles for H1-ECs and Pericytes during Vascular Assembly {#sec2.3}
-------------------------------------------------------------------------------------------------------------------

A comparison of H1-EC or pericyte monocultures in PEG hydrogels identified distinct patterns of functional genes for each cell type. Characteristic gene expression signatures for H1-ECs and pericytes cultured in PEG hydrogels were defined as genes differentially expressed by EBSeq ([@bib29]) on each of the first 3 days of culture. In total, there were 636 upregulated genes for H1-ECs and 921 upregulated genes for pericytes that overlapped on days 1--3 of culture in PEG hydrogels ([Table S4](#mmc5){ref-type="supplementary-material"}, "H1-EC1"). H1-ECs and pericytes were characterized by distinct patterns of expressed genes associated with vasculature development ([Figure 3](#fig3){ref-type="fig"}), cellular adhesion (e.g., integrins), ECM assembly (e.g., collagen, laminin, and fibronectin), and proteolysis (e.g., MMPs). For example, while H1-ECs were characterized by upregulated expression of *PDGFB*, *KDR*, and *CXCR4*, pericytes expressed the complementary genes *PDGFRB*, *VEGFA*, and *CXCL12* (similar results for HUVECs, [Table S4](#mmc5){ref-type="supplementary-material"}, "HUV1"), which is consistent with growth-factor-receptor interactions known to guide blood vessel formation and stabilization ([@bib17]).

Both H1-ECs and pericytes cultured in PEG hydrogels expressed ECM genes associated with basement membrane assembly, including collagen IV and laminin isoforms, similar to ECM components previously identified for vascular networks in collagen ([@bib58]) and PEG hydrogels ([@bib39]). However, pericytes were characterized by upregulated expression of several structural ECM genes compared with H1-ECs, including collagen I and collagen III isoforms (*COL1A1*, *COL1A2*, and *COL3A1*). Genes implicated in the assembly of collagen I and III matrices were also upregulated by pericytes, including fibronectin (*FN1*) and α11-integrin (*ITGA11*) ([@bib59], [@bib64]). Finally, pericytes were characterized by enriched α10-integrin (*ITGA10*) and several α10-integrin receptors, including isoforms for laminin-1 (*LAMA1*) and collagen VI (*COL6A1*, *COL6A2*, and *COL6A3*) ([@bib62]), which is a collagen subtype that was previously shown to bind von Willebrand factor (*VWF*) within the vascular subendothelium ([@bib13], [@bib20]). Genes upregulated for H1-ECs relative to pericytes included α6-integrin (*ITGA6*) ([@bib4]) and heparin sulfate proteoglycan (*HSPG2*), which interact with VEGFA to guide vascular branching ([@bib52]). H1-ECs were also characterized by upregulated α9-integrin (*ITGA9*), which is an integrin isoform that plays a role during angiogenesis by binding VEGFA and thrombosponin-1 (*THSD1*, also upregulated by H1-ECs) ([@bib57], [@bib65]). Many differentially expressed genes for H1-ECs and pericytes cultured in PEG hydrogels were also identified for comparisons between HUVECs and pericytes ([Table S4](#mmc5){ref-type="supplementary-material"}). Thus, gene expression patterns for endothelial cells and pericytes cultured in PEG hydrogels are consistent with reciprocal signaling that guides blood vessel formation and stabilization in vivo ([@bib11], [@bib17], [@bib45]).

H1-ECs Cultured on Tissue-Culture Polystyrene Surfaces Were Characterized by a Proliferative Phenotype that Was Regulated by FAK-ERK Activity {#sec2.4}
---------------------------------------------------------------------------------------------------------------------------------------------

Upregulated genes for H1-ECs cultured in PEG hydrogels were associated with functional characteristics such as vascular development, cell adhesion, and cell migration compared with cells on TCP surfaces, while downregulated genes (higher expression on TCP) were predominantly associated with the cell cycle and mitosis ([Table S5](#mmc6){ref-type="supplementary-material"}). HUVECs and pericytes were also characterized by upregulated expression of functional genes in PEG hydrogels and cell proliferation genes on TCP surfaces ([Table S5](#mmc6){ref-type="supplementary-material"}), and similar results were previously reported for iPSC-ECs ([@bib72]). Outside-in signaling through focal adhesion kinase (FAK) and mitogen-activated protein kinase (MAPK/ERK) is important for diverse mechanisms of blood vessel morphogenesis, including proliferation, angiogenesis, and tube formation ([@bib23], [@bib45], [@bib68]). Therefore, we investigated potential roles for FAK ([Figure 4](#fig4){ref-type="fig"}) and ERK ([Figure 5](#fig5){ref-type="fig"}) in mediating the differences in gene expression for H1-ECs cultured in PEG hydrogels compared with cells cultured on TCP surfaces. H1-ECs cultured on TCP were characterized by increased phosphorylation for both FAK (pFAK, [Figure 4](#fig4){ref-type="fig"}A) and ERK1/2 (pERK1/2, [Figure 5](#fig5){ref-type="fig"}A) compared with cells cultured in PEG hydrogels. Phosphorylated VEGF-receptor 2 (VEGFR2/KDR) expression for H1-ECs cultured on TCP was similar compared with cells cultured in PEG hydrogels ([Figure 5](#fig5){ref-type="fig"}A), which indicates that elevated FAK-ERK activity was not correlated with VEGF/VEGFR2 signaling. Inhibition of FAK (I-14; [Figures 4](#fig4){ref-type="fig"}B and 4C) or MEK/MAPKK (UO126; [Figures 5](#fig5){ref-type="fig"}B and 5C) ([@bib15]), an upstream regulator of ERK phosphorylation ([@bib1]) each corresponded to reduced pERK expression and decreased proliferation. Therefore, FAK-ERK activity regulated the proliferative phenotype for H1-ECs cultured on TCP surfaces.

Inhibition of ERK Pathway Signaling Rescues Aspects of the 3D Phenotype for H1-ECs Cultured on TCP {#sec2.5}
--------------------------------------------------------------------------------------------------

Based on our combined results, we hypothesized that gene expression associated with the 3D phenotype could be rescued for H1-ECs cultured on TCP by reducing FAK-ERK signaling. To test this hypothesis, we treated H1-ECs cultured on TCP with inhibitors of FAK and ERK expression, and RT-PCR was used to compare highly expressed cell-cycle genes for H1-ECs cultured on TCP and "3D-like" functional genes identified for cells cultured in PEG hydrogels ([Figure S3](#mmc1){ref-type="supplementary-material"}). FAK inhibition reduced expression for both cell cycle and the 3D-like genes by H1-ECs cultured on TCP (I-14, [Figure 4](#fig4){ref-type="fig"}D), which is consistent with the importance of outside-in signaling for regulating diverse cellular functions relevant to blood vessel morphogenesis ([@bib23], [@bib45], [@bib68]). However, MEK inhibition ([Figure 5](#fig5){ref-type="fig"}D) and *ERK2* silencing by small interfering RNA (siRNA) ([Figure 5](#fig5){ref-type="fig"}E) each reduced expression of proliferative 2D genes while also increasing expression for 3D-like genes. Our combined results demonstrate that H1-ECs cultured on TCP adopted a proliferative phenotype that was regulated by FAK-ERK signaling, while 3D-like gene expression could be rescued by reducing ERK pathway signaling.

Cells Cultured on TCP Surfaces Adopt a Proliferative Phenotype Compared with Cells Cultured on Top of or Encapsulated in PEG Hydrogels and Gelled Matrigel {#sec2.6}
----------------------------------------------------------------------------------------------------------------------------------------------------------

Cells cultured on TCP are exposed to a non-physiological planar surface and a modulus that is orders of magnitude higher than most tissues ([@bib9], [@bib36]) as well as the PEG hydrogels used here (∼200--1,600 Pa for a similar range) ([@bib72]) or Matrigel (values ranging from ∼34 to 450 Pa have been reported) ([@bib54], [@bib56]). Therefore, we hypothesized that mechanical properties play an important role for inducing proliferative phenotypes when cells are cultured on TCP surfaces. Consistent with this hypothesis, the proliferation rate for H1-ECs cultured on TCP was higher than for cells cultured on top of (2D seeding) or encapsulated in (3D seeding) PEG hydrogels or Matrigel ([Figure S3](#mmc1){ref-type="supplementary-material"}). Furthermore, EBSeq analysis demonstrated that endothelial cells cultured on TCP surfaces consistently upregulated cell-cycle genes compared with cells cultured on or encapsulated in PEG hydrogels or Matrigel ([Tables S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc7){ref-type="supplementary-material"}). However, the proliferation rate was similar for H1-ECs cultured on top of or encapsulated in PEG hydrogels or Matrigel ([Figure S3](#mmc1){ref-type="supplementary-material"}), and upregulated genes were not associated with a proliferative signature for H1-ECs or HUVECs cultured on PEG hydrogels compared with encapsulated cells ([Table S6](#mmc7){ref-type="supplementary-material"}). Differential gene expression analysis did not identify GO terms for either condition when H1-ECs cultured on gelled Matrigel were compared with cells encapsulated in PEG hydrogels ([Table S5](#mmc6){ref-type="supplementary-material"}), and gene expression profiles for H1-ECs cultured on Matrigel were better correlated with cells cultured in PEG hydrogels than cells cultured on TCP surfaces ([Figure S3](#mmc1){ref-type="supplementary-material"}). We note that genes associated with the cell cycle and mitosis were identified for HUVECs cultured on top of gelled Matrigel compared with cells encapsulated in Matrigel ([Table S6](#mmc7){ref-type="supplementary-material"}, see "DE HUV2" tab), although further investigation would be required to demonstrate that this result is due to the 2D environment rather than other factors (e.g., differences in nutrient diffusion). Taken together, our combined results strongly suggest that cells adopt a proliferative phenotype on TCP surfaces due to the stiffness of the substrate.

Discussion {#sec3}
==========

Matrix mechanical properties have been implicated in pathological conditions such as fibrotic diseases and cancer ([@bib9]), and increased matrix stiffness has been linked to the disruption of epithelial organization and activation of a proliferative signature through increased FAK-ERK signaling ([@bib51]). Here, H1-ECs cultured on TCP surfaces were characterized by increased proliferation, upregulated expression of cell-cycle genes, and increased FAK-ERK activity compared with cells encapsulated in PEG hydrogels. Inhibition or knockdown of ERK signaling for H1-ECs cultured on TCP resulted in reduced proliferation, downregulated expression of cell-cycle genes, and increased expression for "3D-like" vasculature development genes. Proliferation was similar for H1-ECs cultured on or encapsulated in PEG hydrogels, which suggests that the proliferative phenotype on TCP is not an inherent consequence of 2D culture. Importantly, EBSeq analysis demonstrated that cells cultured on TCP surfaces consistently upregulated cell-cycle genes compared with cells cultured on or encapsulated in hydrogels, which was true regardless of cell type (H1-ECs, HUVECs, or pericytes), culture platform (PEG or Matrigel), or surface coating (vitronectin, Matrigel, or poly-L-lysine). Based on these combined results, we speculate that cells cultured on TCP surfaces adopt a phenotype that is inappropriate for studying mechanisms of cellular self-organization due to a modulus that is orders of magnitude higher ([@bib36]) than PEG hydrogels ([@bib72]) or Matrigel ([@bib54], [@bib56]).

Reconstituted basement membrane gels such as Matrigel are widely used to investigate tubule formation by endothelial cells ([@bib2], [@bib26]), and the success of these assays has been attributed to the presentation of a complex mixture of growth factors and ECM components that regulate vascular function. Here, MMP-degradable crosslinks ([@bib40]) and CRGDS cell adhesion ligands ([@bib48]) were the only bioactive components necessary to promote vascular network formation in PEG hydrogels, which is consistent with previous studies that have reported in vitro and in vivo vascularization using synthetic culture platforms ([@bib6], [@bib8], [@bib27], [@bib39], [@bib42], [@bib47], [@bib63], [@bib72]). Cocultured endothelial cells and pericytes remodel the ECM by producing basement membrane proteins during vascular network formation in collagen ([@bib58]) and PEG hydrogels ([@bib39]), and RNA-seq results here identified gene expression patterns for H1-ECs and pericytes associated with similar ECM components. Therefore, when combined with previous studies ([@bib39]), our results suggest that minimally complex PEG hydrogels provide the necessary cues for cellular self-organization, but that remodeling of the surrounding matrix plays an important role during vascular network formation.

Global gene expression patterns were comparable for H1-ECs and pericytes cocultured in PEG hydrogels with 35%--60% crosslinking density and Matrigel, which was surprising given the wide range of biochemical and mechanical properties tested. However, we note that caution is warranted when comparing culture platforms solely based on global gene expression profiles, since regulation of vascular morphogenesis likely differs at the protein modification level in different materials. For example, while H1-ECs cultured on TCP surfaces were characterized by higher ERK activation than cells in PEG hydrogels, total ERK expression was similar for both formats, and such protein modification level differences likely exist for 3D culture materials with the wide range of biochemical and mechanical properties tested here. Nevertheless, our results demonstrate that synthetic hydrogels can be designed to regulate global gene expression patterns similarly to a "gold standard" material such as Matrigel by incorporating a minimal set of bioactive components. Taken together, our combined results offer insight into the influence of 2D and 3D cell-culture platforms on global gene expression programs that regulate vascular function.

Experimental Procedures {#sec4}
=======================

See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for additional details.

Cell Maintenance {#sec4.1}
----------------

Human PSCs were maintained in Essential 8 (E8) medium on Matrigel-coated (BD Biosciences, \#356230) tissue-culture plates and were passaged with EDTA, except for the 005B23.1 iPSC line, which was maintained on recombinant vitronectin-coated plates ([@bib7]). HUVECs (Lonza) were maintained in EGM growth medium (Lonza) according to manufacturer\'s instructions. Human brain vascular pericytes (ScienCell) were maintained in Pericyte Medium (Catalog \#1201, ScienCell) according to manufacturer\'s instructions. Purified or passaged ESC/iPSC-derived endothelial cells were cultured on recombinant vitronectin-coated plates (1 μg/cm^2^; VTN-N, produced in house) ([@bib7]) and maintained in E7V medium.

Endothelial Cell Differentiation, Purification, and Culture {#sec4.2}
-----------------------------------------------------------

Human ESCs/iPSCs were passaged with EDTA 2 days before the differentiation to achieve maximum efficiency and consistent results. On the day of differentiation, human ESCs/iPSCs at 80%--90% confluency were dissociated with Accutase (Invitrogen) and plated 1:3 (∼1 × 10^5^ cells/cm^2^) on vitronectin-coated plates (1 μg/cm^2^). ESCs/iPSCs were differentiated into mesoderm by culturing for 44 hr in E8BA medium supplemented with 10 μM Y27632 for the first day to improve cell survival (note that 100% cell confluency at day 2 is critical to achieving high efficiency). Mesoderm was then cultured for 3 days in E7BVi medium. Addition of 1 μM CHIR 99021 ([@bib32]) to the mesoderm differentiation medium (E8BAC) and one passage (to day 7) improved differentiation efficiency and eliminated the need for further purification (see [Figure S1](#mmc1){ref-type="supplementary-material"} and [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). Endothelial cells were derived from H1 ESCs using E8BA mesoderm medium for RNA-seq experiment \#1 (referred to as "H1-EC1") and from H1-FUCCI ESCs ([@bib30]) in E8BAC mesoderm medium for RNA-seq experiment \#2 (referred to as "H1-EC2").

Polyethylene Glycol Hydrogel Preparation {#sec4.3}
----------------------------------------

The procedure for fabricating synthetic PEG hydrogels using thiolene photopolymerization was modified from the original protocol ([@bib14]) and has been described in detail ([@bib72]). PEG hydrogels were formed by crosslinking 8-arm PEG-norbornene molecules (20,000 MW, JenKem, 8ARM (TP)-NB-20K) with an MMP-degradable peptide (GenScript, KCG**GPQGIWGQ**GCK, active sequence in bold) ([@bib40]), while cell adhesion was promoted using a pendant CRGDS peptide (GenScript) ([@bib48]). Cell/monomer solutions were polymerized for 2 min under ∼5--10 mW/cm^2^ UV light centered at ∼365 nm (top shelf of Exposure Stand for UVP XX-15L series UV lamp, Fisher). The gels were then immersed in medium for the duration of the experiment.

Matrigel Assays {#sec4.4}
---------------

### 3D Matrigel Tube-Forming Assay {#sec4.4.1}

A 10-μL monomer/cell solution (1.5 × 10^6^ endothelial cells/mL in 5 mg/mL Matrigel) was spotted in a well of a 24-well plate and incubated for 5 min at 37°C for solidification and then cultured for 4 days before harvesting ([Figure 1](#fig1){ref-type="fig"}F).

### In Vivo Matrigel Plug Angiogenesis Assay {#sec4.4.2}

This animal study was conducted with approval from the UW-Madison School of Medicine and Public Health Animal Care and Use Committee. A total of 5 × 10^5^ endothelial cells were suspended in 100 μL of E7V medium and 200 μL of Matrigel. The 300-μL mixture was subcutaneously injected into the neck of nude mice and harvested 2 weeks after inoculation ([Figure 1](#fig1){ref-type="fig"}G).

RNA Sequencing {#sec4.5}
--------------

### RNA-Seq Experiment \#1 {#sec4.5.1}

For further details, see [Table S1](#mmc2){ref-type="supplementary-material"}. Encapsulated cells in PEG hydrogels (30 μL, 35%--50% crosslinking density, 0--2 mM CRGDS) or Matrigel (4.5 mg/mL) were maintained under hypoxic conditions (1.5% O~2~) in E7V medium supplemented with 1% BSA. H1-ECs were cultured on top of gelled Matrigel (4.5 mg/mL) under normoxic conditions in E7V medium supplemented with 1% BSA. TCP surfaces were coated with Matrigel (H1 ESCs, "H1-ESC-1"), recombinant vitronectin (H1-ECs, "H1-EC1"; HUVECs, "HUV1"), or poly-L-lysine (pericytes, "PC"), and cells were cultured in maintenance medium (E7V + 1% BSA for H1-EC1) under normoxic conditions. Cells cultured on TCP were 100% confluent when RNA was collected. Samples were prepared using Illumina\'s TruSeq RNA sample preparation kit and followed a protocol previously described in detail ([@bib72]).

### RNA-Seq Experiment \#2 {#sec4.5.2}

H1-ECs ("H1-EC2") or HUVECs ("HUV2") were encapsulated in or seeded on PEG hydrogels (50% crosslinking, 2 mM CRGDS) or gelled Matrigel (6.4 mg/mL) formed in multiwell plates or on TCP surfaces coated with a dilute solution of Matrigel. Samples were prepared followed a custom "LM-Seq" protocol previously described in detail ([@bib19]).

### RNA-Seq Data Analysis {#sec4.5.3}

The cDNA libraries were pooled and run on Illumina\'s HiSeq 2500. FASTQ files of nucleotide sequences were generated by CASAVA (v1.8.2) and reads were mapped to the human transcriptome with Bowtie (v0.12.8) ([@bib28]). Normalized gene expression (transcripts per million reads, or TPM) was calculated by RSEM (RNA-seq by expectation maximization) (v1.2.3) ([@bib31]). EBSeq (v1.5.3) was used to calculate differentially expressed genes using the RSEM expected read counts (EC) with the maximum FDR set at 0.005 for all comparisons. EBSeq for replicate samples was used for RNA-seq experiment \#2. Details about the EBSeq algorithms were previously described in detail ([@bib29]). GO terms were identified using the DAVID Bioinformatics Database (Resources version 6.7) Functional Annotation Tool ([@bib3], [@bib12], [@bib21]).

Previous Dataset Used in This Study {#sec4.6}
-----------------------------------

RNA-seq processing for EBSeq analysis and normalized gene expression for quadruplicate H1-ESC samples ([Table S1](#mmc2){ref-type="supplementary-material"}, "H1-ESC-2") used a previously deposited dataset ([@bib53]).

Statistical Analysis {#sec4.7}
--------------------

Statistical significance was determined using Student\'s t test for all quantification except RNA-seq analysis. Data are presented as means ± SD for at least three replicate samples (see figure legends for additional details). Differential gene expression analysis via EBSeq for RNA-seq data is described in the section "RNA-Seq Data Analysis."

Author Contributions {#sec5}
====================
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Accession Numbers {#app1}
=================

RNA-seq data for this study are available through GEO Series accession number GEO: [GSE93511](ncbi-geo:GSE93511){#intref0010} (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE93511>).
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![Protocol for Deriving Endothelial Cells from Human Pluripotent Stem Cells\
(A) Human PSCs were differentiated into endothelial cells via a mesoderm intermediate ([Figure S1](#mmc1){ref-type="supplementary-material"} provides representative data for the modified "E8BAC" protocol).\
(B) Representative yields (CD34^+^CD31^+^ cells) by flow cytometric analysis for ESC-derived endothelial cells (H1-ECs) after 5 days of differentiation followed by one passage (to day 7).\
(C and D) H1-ECs (C) upregulated KDR and downregulated NANOG and OCT4 by FACS analysis and (D) downregulated pluripotent genes by RNA-seq. H1-EC1, original differentiation protocol; H1-EC2, modified differentiation protocol; HUVECs, human umbilical vein endothelial cells.\
(E--G) H1-ECs also (E) took up LDL and formed capillary networks in Matrigel (F) in vitro (CD31, green) and (G) in vivo (human CD31, green; mouse CD31, red). For the in vivo condition, 5 × 10^5^ endothelial cells were suspended in 100 μL of E7V medium and 200 μL of Matrigel, injected subcutaneously into the neck of nude mice, and harvested for immunostaining after 2 weeks. Scale bars, 50 μm.\
(H) The top ten gene ontology (GO) terms identified using the DAVID functional annotation database for upregulated genes by H1-endothelial cells relative to H1 ESCs cultured on TCP surfaces. Upregulated genes for HUVECs are shown in the same GO categories. Undifferentiated H1 ESCs treated with the same antibodies were used as gating controls for FACS experiments illustrated in (A) and (B). See [Table S2](#mmc3){ref-type="supplementary-material"} for full DE gene lists.](gr1){#fig1}

![A Comparison of H1-ECs Cocultured with Pericytes in PEG Hydrogels or Matrigel\
(A--D) H1-ECs were cocultured with primary human pericytes (PCs) in (A--C) polyethylene glycol (PEG) hydrogels with 35%--60% MMP-degradable peptide crosslinks or (D) Matrigel. Scale bars, 1000 μm.\
(E) GO terms for genes upregulated by H1-EC-PC cocultures over H1 ESCs (FDR ≤ 0.005) were identified using the DAVID functional annotation database. The top ten GO terms are shown for upregulated genes that overlapped for H1-EC-PC cocultures in both PEG hydrogels and Matrigel on each of the first three days of culture ("Both"). The number of upregulated genes that overlapped on days 1--3 for H1-EC-PC cocultures in PEG hydrogels alone ("PEG") or Matrigel alone ("Matrigel") for the same GO categories are also shown. See [Table S3](#mmc4){ref-type="supplementary-material"} for full lists of DE genes and GO terms.](gr2){#fig2}

![Vasculature Development Genes Robustly Expressed by H1-ECs or Pericytes\
Upregulated genes (FDR ≤ 0.005) for H1-ECs (top) or pericyte (bottom, reverse order) that overlapped on days 1--3 of culture in PEG hydrogels (data from RNA-seq experiment \#1). Genes were ranked within the GO category "vasculature development (GO:0001944)" based on average normalized expression (TPM) for H1-ECs or pericytes in 3D culture on days 1--3. H1 ESCs, 2D monocultured H1-ECs, pericytes, and H1-EC-PC cocultures in PEG hydrogels or Matrigel are shown for comparison. See [Table S4](#mmc5){ref-type="supplementary-material"} for comparisons of normalized expression for H1-ECs and HUVECs from RNA-seq experiment \#2.](gr3){#fig3}

![FAK Signaling and Differentially Expressed Genes for H1-ECs Cultured on TCP Surfaces or in PEG Hydrogels\
(A and B) Western blot analysis for H1-ECs cultured on TCP surfaces or in PEG hydrogels. (A) Total and phosphorylated FAK expression by H1-ECs cultured on TCP (2D) or in PEG hydrogels (3D). (B) Total and phosphorylated FAK or ERK1/2 expression by H1-ECs cultured on TCP surfaces after treatment with 0 μM (untreated control) or 20 μM Inhibitor-14 (I-14, pFAK inhibitor). Protein was collected 1 day after encapsulation for H1-ECs in PEG hydrogels and 2 days after plating on TCP surfaces (cells were 100% confluent).\
(C) I-14 treatment for H1-ECs in 2D culture resulted in decreased proliferation (FACS analysis of 5-ethynyl-2′-deoxyuridine \[EdU\] expression). Data are presented as mean ± SD (n = 3 independent experiments; ^∗^p \< 0.05).\
(D) qRT-PCR was used to investigate changes in gene expression for H1-ECs cultured on TCP surfaces in response to treatment with pFAK inhibitor (I-14). Gene expression was normalized to untreated control (dashed line, RE = 1). Data are presented as mean ± SD (n = 4 technical replicates; triplicate samples prepared from separate cryopreserved vials of the same differentiation were pooled for analysis; p \< 0.05 for all genes except *ADM* and *PDGFA*). RNA-seq was used to identify differentially expressed genes upregulated by H1-ECs cultured in PEG hydrogels (top, associated with AmiGO term "GO:0001944: vasculature development") or on TCP surfaces (bottom, from the AmioGO term "GO:0007049: cell cycle"), as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc6){ref-type="supplementary-material"}.](gr4){#fig4}

![The ERK/MAPK Signaling Pathway Modulates H1-EC Phenotypes for Cells on TCP Surfaces or in PEG Hydrogels\
(A and B) Western blot analysis for H1-ECs cultured on TCP surfaces or in PEG hydrogels. (A) Total and phosphorylated ERK and VEGFR2/KDR for H1-ECs cultured on TCP surfaces (2D) or in PEG hydrogels (3D). (B) Total and phosphorylated ERK expression as a function of MEK inhibitor concentration (U0126, μM) for H1-ECs cultured on TCP surfaces. Protein was collected 1 day after encapsulation for H1-ECs in PEG hydrogels and 2 days after plating on TCP surfaces (cells were 100% confluent).\
(C) Click-it EdU assay demonstrates that 4 μM U0126 treatment decreases H1-EC proliferation. Data are presented as mean ± SD (n = 3 independent experiments; ^∗^p \< 0.05).\
(D and E) qRT-PCR was used to investigate changes in gene expression for H1-ECs cultured on TCP surfaces in response to (D) treatment with the MEK inhibitor UO126 or (E) knockdown of *ERK2* by siRNA. Gene expression was normalized to DMSO control for MEK inhibition and to a non-targeting (NT) control for *ERK2* knockdown by siRNA. Data are presented as mean ± SD (n = 4 technical replicates; triplicate samples prepared from separate cryopreserved vials of the same differentiation were pooled for analysis; p \< 0.05 for all genes except 10 μM *CXCR4* and 4 μM *FOXM1* for MEK inhibition; p \< 0.05 for all genes except *ADM* and *PDGFA* for *ERK2* knockdown). RNA-seq was used to identify differentially expressed genes upregulated by H1-ECs cultured in PEG hydrogels (top, associated with AmiGO term "GO:0001944: vasculature development") or on TCP surfaces (bottom, from the AmioGO term "GO:0007049: cell cycle"), as described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S5](#mmc6){ref-type="supplementary-material"}.](gr5){#fig5}
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